KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Total Debt (2016 - 2023)

Historic Total Debt for Pacific Biosciences Of California (PACB) over the last 13 years, with Q3 2023 value amounting to $96.2 million.

  • Pacific Biosciences Of California's Total Debt changed N/A to $96.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $96.2 million, marking a year-over-year change of. This contributed to the annual value of $172.6 million for FY2022, which is 431642.78% up from last year.
  • According to the latest figures from Q3 2023, Pacific Biosciences Of California's Total Debt is $96.2 million.
  • Pacific Biosciences Of California's 5-year Total Debt high stood at $186.3 million for Q2 2023, and its period low was $3.9 million during Q4 2021.
  • Over the past 4 years, Pacific Biosciences Of California's median Total Debt value was $134.4 million (recorded in 2022), while the average stood at $109.9 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Total Debt skyrocketed by 778.36% in 2019, and later surged by 431642.78% in 2022.
  • Over the past 4 years, Pacific Biosciences Of California's Total Debt (Quarter) stood at $15.8 million in 2019, then plummeted by 75.27% to $3.9 million in 2021, then surged by 4316.43% to $172.6 million in 2022, then plummeted by 44.27% to $96.2 million in 2023.
  • Its Total Debt stands at $96.2 million for Q3 2023, versus $186.3 million for Q2 2023 and $184.4 million for Q1 2023.